Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.56 |
| ▸ | SRC | P12931 | 2/20 | 0.52 |
| ▸ | EEF2K | O00418 | 1/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 8/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.50 |
| ▸ | TTR | P02766 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | ERN1 | O75460 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL299751 | 0.88 | EGFR (0.53) | CYP2C9CYP1A2CYP3A4CYP2D6CYP2B6 | |
| SCHEMBL29459683 | 0.88 | EGFR (0.53) | CYP2C9CYP1A2CYP3A4CYP2D6CYP2B6 | |
| Benzaldehyde SCHEMBL27604595 | 0.87 | PTGS1 (0.66) | CYP2C9CYP1A2CYP3A4CYP2D6CYP2B6 | |
| SCHEMBL5646596 | 0.86 | ERN1 (0.56) | CYP2C9CYP1A2CYP3A4CYP2D6CYP2B6 | |
| SCHEMBL6740604 | 0.86 | ERN1 (0.45) | CYP2C9CYP1A2CYP3A4CYP2D6CYP2B6 | |
| SCHEMBL12687888 | 0.84 | SRC (0.47) | CYP2C9CYP1A2CYP3A4CYP2D6CYP2B6 | |
| SCHEMBL670883 | 0.84 | PTGS1 (0.49) | CYP2C9CYP1A2CYP3A4CYP2D6CYP2B6 | |
| SCHEMBL13851317 | 0.84 | KDM4E (0.54) | CYP2C9CYP1A2CYP3A4CYP2D6CYP2B6 | |
| SCHEMBL12552996 | 0.84 | ERN1 (0.44) | CYP2C9CYP1A2CYP3A4CYP2D6CYP2B6 | |
| SCHEMBL12593986 | 0.84 | PTGS1 (0.47) | CYP2C9CYP1A2CYP3A4CYP2D6CYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1919 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12351586-B2 | Thiophene[2,3-d]pyrimidine derivative DK6-1 and its preparation method and application | SHAN DONG UNIVERSITY (CN) | 2025-07-08 | — | — | US | claimed |
| CN-119859280-A | Porphyrin pigment derivative and preparation method thereof, low-temperature black photoresist and preparation method and application thereof | 西安思摩威新材料有限公司 | 2025-04-22 | — | — | CN | claimed |
| CN-116332887-B | Synthesis method and application of orange ketone derivatives with nonalcoholic steatohepatitis resistance | 天津科技大学 | 2024-08-13 | — | — | CN | claimed |
| US-11957793-B2 | Nanoparticles | SINTEF TTO AS (NO) | 2024-04-16 | — | — | US | claimed |
| WO-2024071594-A1 | COMPOSITION COMPRISING QUINAZOLINE SALT COMPOUND FOR TREATMENT OF ARTHRITIS AND PREPARATION METHOD THEREFOR | 주식회사 베노바이오 | 2024-04-04 | — | — | WO | claimed |
| CN-112584824-B | Nanoparticles | 新泰福托特股份有限公司 | 2024-03-29 | — | — | CN | claimed |
| US-11918671-B2 | Multi-tone hair dyeing method in three steps | HENKEL AG & CO. KGAA (DE) | 2024-03-05 | — | — | US | claimed |
| CN-117486883-A | Purinyl fluorescent probe EDPH and application thereof in detection of content of hydrogen sulfide or Hela cell imaging | 江苏科技大学 | 2024-02-02 | — | — | CN | claimed |
| CN-117088760-A | Drug molecule for selectively inhibiting human breast cancer cells and application thereof | 河北北方学院 | 2023-11-21 | — | — | CN | claimed |
| CN-116621826-A | Epoxy monomer based on bicyclic acetal structure, and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2023-08-22 | — | — | CN | claimed |
| EP-1066269-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-01-10 | — | — | EP | claimed |
| EP-1054657-A1 | AGENT FOR COLORING FIBERS | Wella Aktiengesellschaft (DE) | 2000-11-29 | — | — | EP | claimed |
| US-6150360-A | ADMINISTERING TO A PATIENT SUFFERING FROM HUMAN IMMUNODEFICIENCY VIRUS INFECTION A TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVE | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-11-21 | — | — | US | claimed |
| WO-2000033799-A1 | AGENT FOR COLORING FIBERS | WELLA AKTIENGESELLSCHAFT (DE) | 2000-06-15 | — | — | WO | claimed |
| WO-1999050256-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-10-07 | — | — | WO | claimed |
| EP-0212095-B1 | THERMOSETTABLE COMPOUNDS PREPARED FROM MONOHYDROXY AROMATIC ALDEHYDES AND METHYLATED PYRIDINES OR PYRAZINES | THE DOW CHEMICAL COMPANY (US) | 1989-09-06 | — | — | EP | claimed |
| EP-0212095-A1 | Thermosettable compounds prepared from monohydroxy aromatic aldehydes and methylated pyridines or pyrazines | THE DOW CHEMICAL COMPANY (US) | 1987-03-04 | — | — | EP | claimed |
| EP-0193257-A1 | Control of micro-organisms in water-containing compositions | NIPA LABORATORIES, LTD. (GB) | 1986-09-03 | — | — | EP | claimed |
| US-4600767-A | Thermostable hydroxystyrylaza compounds | THE DOW CHEMICAL COMPANY (US) | 1986-07-15 | — | — | US | claimed |
| US-4578439-A | Styryl pyridine cyanates, styryl pyrazine cyanates and polymers thereof | THE DOW CHEMICAL COMPANY (US) | 1986-03-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12351586-B2 | Thiophene[2,3-d]pyrimidine derivative DK6-1 and its preparation method and application | CXCR6, TYMP, CDK6 | CYP2C9 1575/4885CYP1A2 2619/4885CYP3A4 1057/4885 |
| US-11957793-B2 | Nanoparticles | CBR3, CBR1, AKR1C3 | CYP2C9 373/4885CYP1A2 281/4885CYP3A4 233/4885 |
| US-11918671-B2 | Multi-tone hair dyeing method in three steps | TYR, HAO2, HAAO | CYP2C9 1050/4885CYP1A2 650/4885CYP3A4 2007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.